CTGF gene inhibitor (Towa Pharmaceuticals/Niigata University)

N/A

Report date: 2025/03/18 18:12:38
NME

Base Information

Drug NameCTGF gene inhibitor (Towa Pharmaceuticals/Niigata University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionConnective tissue growth factor inhibitors
TargetsConnective tissue growth factor
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTowa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNiigata UniversityTowa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A